Advancing Animal Health Through Better Bioanalysis

Supporting veterinary drug developers with specialized bioanalytical expertise, advanced analytical technologies and quality systems designed to accelerate development while meeting evolving regulatory expectations.

Why We Invest in Animal Health

Emerging peptide therapeutics, monoclonal antibodies, precision medicines and novel delivery technologies are expanding what’s possible in veterinary medicine. At the same time, evolving regulatory expectations and increasingly complex analytical requirements are raising the bar for bioanalysis.

Animal health innovation deserves the same scientific rigor, analytical capabilities and quality standards as human drug development. From companion animals to livestock, veterinary medicines improve health, food security and quality of life worldwide.

As these programs become more sophisticated, sponsors need scientific partners with the analytical capabilities, quality systems and regulatory understanding to help move promising therapies forward. Veloxity has intentionally built scientific capabilities, quality systems and thought leadership to better support animal health sponsors throughout development.

Featured Resources

Updates in Animal Health Bioanalysis

Transitioning to the ICH M10 Bioanalytical Guidance

Learn how evolving regulatory expectations are shaping veterinary bioanalysis and how Veloxity helped advance broader adoption of ICH M10 guidance for animal health studies. 

Six Quality Disciplines That Enable Predictable, Inspection-Ready Bioanalysis

Quality isn’t something inspected at the end of a study.

Discover how integrated quality systems reduce rework, improve predictability and help programs move faster. 

Early HRMS Performance Data

Quantitation for Peptides and GLP-1 Bioanalysis

See how the SCIEX ZenoTOF 8600 demonstrated substantial sensitivity improvements for peptide bioanalysis and emerging biologic therapeutics. 

Validated HPLC-MS/MS Method for Semaglutide Analysis

Learn how researchers developed and validated a robust HPLC-MS/MS assay for semaglutide in human plasma, creating a reliable method for clinical bioanalysis and future GLP-1 therapeutics. Read the full publication for the complete findings.

Why Sponsors Choose Veloxity

Specialized Animal Health Experience

Purpose-built workflows supporting veterinary therapeutics.

Advanced LC-MS & HRMS

Small molecules, peptides, proteins and complex biologics.

Built-in Quality, By Design

Integrated quality systems designed to reduce delays and improve confidence.

Industry’s Fastest Turnaround Times

Rapid study initiation with responsive scientific collaboration.

Let's Meet at the Animal Health Summit

Attending the 2026 Animal Health Summit, August 31st – September 1st, in Kansas City, MO?

We’d love to discuss your upcoming animal health programs and explore how Veloxity can support your next study.